AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$7.42 USD
-0.13 (-1.72%)
Updated Aug 27, 2024 03:59 PM ET
After-Market: $7.40 -0.02 (-0.27%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for AngioDynamics, Inc falls in the month of May.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -184.35 | -52.44 | -26.55 | -31.55 | -166.79 |
Depreciation/Amortization & Depletion | 187.19 | 45.42 | 29.35 | 25.92 | 23.81 |
Net Change from Assets/Liabilities | 14.42 | -7.03 | -21.05 | 9.07 | -28.55 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -45.42 | 14.12 | 11.05 | 20.65 | 156.98 |
Net Cash From Operating Activities | -28.16 | 0.08 | -7.19 | 24.09 | -14.55 |
Property & Equipment | 131.98 | -3.81 | -4.30 | -5.19 | -7.24 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -3.60 | 0.00 | -55.76 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -8.26 | -5.93 | -11.41 | -8.52 | -0.35 |
Net Cash from Investing Activities | 123.72 | -9.75 | -19.31 | -13.71 | -63.35 |
Uses of Funds
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.75 | 0.00 | 2.68 | 3.01 | -0.76 |
Issuance (Repayment) of Debt | -50.00 | 25.00 | 5.00 | -20.00 | -92.50 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -15.00 | 0.42 | 0.00 | 0.00 | -1.98 |
Net Cash from Financing Activities | -64.25 | 25.42 | 7.68 | -16.99 | -95.24 |
Effect of Exchange Rate Changes | 0.13 | 0.04 | -0.52 | 0.33 | -0.07 |
Net Change In Cash & Equivalents | 31.44 | 15.80 | -19.34 | -6.27 | -173.21 |
Cash at Beginning of Period | 44.62 | 28.83 | 48.16 | 54.44 | 227.64 |
Cash at End of Period | 76.06 | 44.62 | 28.83 | 48.16 | 54.44 |
Diluted Net EPS | -4.59 | -1.33 | -0.68 | -0.82 | -4.39 |
Fiscal Year End for AngioDynamics, Inc falls in the month of May.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -184.35 | -170.90 | 16.84 | 45.88 | -52.44 |
Depreciation/Amortization & Depletion | 187.19 | 20.90 | 13.37 | 6.69 | 45.42 |
Net Change from Assets/Liabilities | 14.42 | 4.70 | -14.11 | -22.12 | -7.03 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -45.42 | 112.15 | -36.73 | -56.35 | 14.12 |
Net Cash From Operating Activities | -28.16 | -33.16 | -20.63 | -25.90 | 0.08 |
Property & Equipment | 131.98 | 132.55 | 98.66 | 99.21 | -3.81 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -8.26 | -6.50 | -2.01 | -0.77 | -5.93 |
Net Cash from Investing Activities | 123.72 | 126.05 | 96.65 | 98.44 | -9.75 |
Uses of Funds
5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.75 | 0.75 | 0.06 | 0.41 | 0.00 |
Issuance (Repayment) of Debt | -50.00 | -50.00 | -50.00 | -50.00 | 25.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -15.00 | -10.00 | -10.00 | -10.00 | 0.42 |
Net Cash from Financing Activities | -64.25 | -59.25 | -59.94 | -59.59 | 25.42 |
Effect of Exchange Rate Changes | 0.13 | 0.19 | 0.20 | 0.01 | 0.04 |
Net Change In Cash & Equivalents | 31.44 | 33.83 | 16.28 | 12.97 | 15.80 |
Cash at Beginning of Period | 44.62 | 44.62 | 44.62 | 44.62 | 28.83 |
Cash at End of Period | 76.06 | 78.45 | 60.90 | 57.59 | 44.62 |
Diluted Net EPS | -0.35 | -4.67 | -0.72 | 1.15 | -0.55 |